PureTech Appoints Robert Lyne as Chief Executive Officer

About this update from Puretech Health Plc

[{"type":"image","alt":"Robert Lyne, Chief Executive Officer of PureTech","displaySize":"","headline":null,"caption":"Robert Lyne, Chief Executive Officer of PureTech","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/0c06aa055443d0f82c43a861a2b2c34a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kOE7DhFC_ZlK4GkLFOx9hw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0c06aa055443d0f82c43a861a2b2c34a","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":7367,"height":2362,"url":"https://media.zenfs.com/en/business-wire.com/98c5eed971105639e94164b3518ee636"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cIl6W8cLh7ekJAFNN14qRw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/98c5eed971105639e94164b3518ee636","width":960,"height":308},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4vxFRMOaQT7lPXeeAiqjaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/98c5eed971105639e94164b3518ee636","width":1200,"height":385}}},{"type":"text","content":"BOSTON, December 18, 2025--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announces that the Board of Directors has appointed Robert Lyne as Chief Executive Officer (CEO), and as a member of the Board of Directors, effective immediately.","length":426,"tagName":"p"},{"type":"text","content":"Robert Lyne commented: "I’m honored to lead PureTech as CEO at such an important moment in its evolution. Over the past two years, I’ve seen first-hand the strength of our programs, the talent of our team, and the power of our differentiated model. I’m keen to build on this foundation, working closely with the Board to drive the next phase of execution as we advance transformative therapies for patients and deliver long-term value for our shareholders.","length":461,"tagName":"p"},{"type":"text","content":""Our immediate focus is on secur...

More updates from Puretech Health Plc